Form 4: Myriad Genetics SVP Margaret Ancona Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, disposed of 730 shares of common stock on March 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 22, 2024, Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, disposed of 730 shares of the company's common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- The shares were disposed of at a price of $22.24 per share.
- Following the transaction, Ancona directly owns 90,904 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 03/22/2024 | Date of stock disposal to cover tax obligations. |
| 03/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.